Lobeglitazone inhibits LPS-induced NLRP3 inflammasome activation and inflammation in the liverHye‐Young Seo(Keimyung University), Byoung Kuk Jang(Keimyung University)PLoS ONEAugust 24, 202310.1371/journal.pone.0290532Cited by 12SaveCiteExport RISWatch citationsRelated PapersThe Autophagy-Related Marker LC3 Can Predict Prognosis in Human Hepatocellular Carcinoma|PLoS ONE|2013|95Src Inhibition Attenuates Liver Fibrosis by Preventing Hepatic Stellate Cell Activation and Decreasing Connective Tissue Growth Factor|Cells|2020|59Kahweol Ameliorates the Liver Inflammation through the Inhibition of NF-κB and STAT3 Activation in Primary Kupffer Cells and Primary Hepatocytes|Nutrients|2018|52Clusterin Attenuates Hepatic Fibrosis by Inhibiting Hepatic Stellate Cell Activation and Downregulating the Smad3 Signaling Pathway|Cells|2019|31Kahweol activates the Nrf2/HO-1 pathway by decreasing Keap1 expression independently of p62 and autophagy pathways|PLoS ONE|2020|22